DK0897914T3 - Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner - Google Patents

Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner

Info

Publication number
DK0897914T3
DK0897914T3 DK98114969T DK98114969T DK0897914T3 DK 0897914 T3 DK0897914 T3 DK 0897914T3 DK 98114969 T DK98114969 T DK 98114969T DK 98114969 T DK98114969 T DK 98114969T DK 0897914 T3 DK0897914 T3 DK 0897914T3
Authority
DK
Denmark
Prior art keywords
formula
compound
chem
signifies
preparation
Prior art date
Application number
DK98114969T
Other languages
English (en)
Inventor
Paul Spurr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0897914T3 publication Critical patent/DK0897914T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/08Preparation by ring-closure
    • C07D213/09Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles
    • C07D213/10Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles from acetaldehyde or cyclic polymers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98114969T 1997-08-19 1998-08-10 Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner DK0897914T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97114269 1997-08-19

Publications (1)

Publication Number Publication Date
DK0897914T3 true DK0897914T3 (da) 2004-09-27

Family

ID=8227241

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98114969T DK0897914T3 (da) 1997-08-19 1998-08-10 Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner

Country Status (10)

Country Link
US (1) US6080866A (da)
EP (1) EP0897914B1 (da)
JP (1) JP3025239B2 (da)
KR (1) KR100275663B1 (da)
CN (1) CN1103335C (da)
AT (1) ATE267808T1 (da)
CA (1) CA2245169C (da)
DE (1) DE69824090T2 (da)
DK (1) DK0897914T3 (da)
ES (1) ES2221696T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US6417360B1 (en) * 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
ZA200002318B (en) * 1999-05-22 2000-11-16 Actelion Pharmaceuticals Ltd Aqueous pharmaceutical composition.
AU2008219065B2 (en) * 2007-02-19 2014-01-30 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
BR112012025844A2 (pt) 2010-04-15 2017-07-18 Marine Polymer Tech Inc uso de nanofibras snag
CA2832859C (en) 2011-04-15 2020-06-16 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers
CA3197265A1 (en) 2020-11-05 2022-05-12 Timo Rager A stable crystalline hydrate of clazosentan disodium salt
JP7820522B2 (ja) 2021-12-17 2026-02-25 ネクセラファーマ株式会社 クラゾセンタン二ナトリウム塩、その製造及びそれを含有する医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571683B2 (en) * 1984-05-23 1988-04-21 Zeneca Ag Products Inc. 2-substituted-5-methylpyridines from methylcyclobutane- carbonitrile, valeronitrile and pentenonitrile intermediates
DE4223013A1 (de) * 1992-07-13 1994-01-20 Bayer Ag Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
US5837708A (en) * 1994-11-25 1998-11-17 Hoffmann-La Roche Inc. Sulphonamides
TW313568B (da) * 1994-12-20 1997-08-21 Hoffmann La Roche

Also Published As

Publication number Publication date
CA2245169A1 (en) 1999-02-19
CN1210105A (zh) 1999-03-10
DE69824090D1 (de) 2004-07-01
EP0897914B1 (en) 2004-05-26
KR19990023680A (ko) 1999-03-25
ES2221696T3 (es) 2005-01-01
JP3025239B2 (ja) 2000-03-27
CN1103335C (zh) 2003-03-19
KR100275663B1 (ko) 2000-12-15
EP0897914A1 (en) 1999-02-24
DE69824090T2 (de) 2005-07-07
ATE267808T1 (de) 2004-06-15
US6080866A (en) 2000-06-27
CA2245169C (en) 2004-08-10
JPH11116554A (ja) 1999-04-27

Similar Documents

Publication Publication Date Title
DK1254883T3 (da) Fremgangsmåde til fremstilling af substitueret 1,1,1-trifluoro-3-butene-2-oner
DK0629609T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamidderivater og et mellemprodukt dertil
DK0733621T3 (da) Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse
NZ507597A (en) Process for synthesizing phenyl substituted pyridine or bipyridine COX-2 inhibitors
EP0077938A3 (en) N-(3-substituted aminophenyl) tetrahydrophthalimides and herbicidal composition
DK0897914T3 (da) Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner
DK539589A (da) Fremgangsmaade til fremstilling af 3-oxo-4-azasteroider
GR3003776T3 (da)
DE68920717D1 (de) Reaktivfarbstoffe.
DE3572816D1 (de) Pyridazinone inotropic agents
EP0435106A3 (en) Liquid crystal compound, liquid crystal composite including the compound and liquid crystal device utilizing the composite
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DK0579059T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
NO179408C (no) Flytende krystallblanding
DK193090D0 (da) Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf
EP0440136A3 (en) Liquid crystal composition and liquid crystal device containing the same
DK0412529T3 (da) Hidtil ukendte imidazolderivater, fremgangsmåde til fremstilling deraf og midler mod mavesår indeholdende disse
IL142760A0 (en) Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'-yl) amino]-cyclopent-2-enyl-methanols
DE58900084D1 (de) Azolylmethylcyclopropane und ihre verwendung als pflanzenschutzmittel.
ATE19241T1 (de) 4-aminomethyl-5-acyl-1,3-dihydro-imidazol-2-one
EP0147788A3 (en) Phenylacetanilide derivatives
ES2141830T3 (es) Derivado de diester fosfonico.
DK0798296T3 (da) Fremgangsmåde til fremstilling af arylamider af heteroaromatiske carboxylsyrer
EP1072588A4 (en) METHOD FOR PRODUCING ARYLSULFENYL HALOGENIDES